NHI National Health Investors Inc

  1. Stocks
  2. Real Estate
  3. NYSE: NHI

Price (delayed)

$73.03

Market cap

$3.54B

P/E Ratio

23.48

Dividend/share

$3.66

EPS

$3.11

Enterprise value

$4.78B

?
Relative Growth: Rel. Growth: 80
Relative Strength: Rel. Strength: 30
Relative Valuation: Rel. Valuation: 36
Relative Profitability: Rel. Profitability: 80

Incorporated in 1991, National Health Investors, Inc. is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. ...

Highlights
The company's revenue rose by 17% YoY and by 7% QoQ
NHI's P/E is 10% less than its 5-year quarterly average of 25.3 and 7% less than its last 4 quarters average of 24.6
National Health Investors's EPS has increased by 2.6% QoQ but it has decreased by 2.2% YoY
The debt has increased by 9% since the previous quarter
The gross margin has declined by 8% year-on-year and by 3.9% since the previous quarter
Sector: Real Estate
Industry: REIT - Healthcare Facilities
Website: http://www.nhireit.com
Peers: NHC ALX STWD BFS

Key stats

What are the main financial stats of NHI

NHI stock price

How has the National Health Investors stock price performed over time
Intraday
2.92%
1 week
1.97%
1 month
-4.44%
1 year
0.95%
YTD
-4.37%
QTD
-9.68%

Financial performance

How have National Health Investors's revenue and profit performed over time
Revenue
$401.46M
Gross profit
$323.22M
Operating income
$198.56M
Net income
$148.11M
Gross margin
80.5%
Net margin
36.9%
The company's revenue rose by 17% YoY and by 7% QoQ
The net margin has declined by 10% year-on-year and by 2.6% since the previous quarter
The operating margin has contracted by 9% YoY and by 4.3% from the previous quarter
The gross margin has declined by 8% year-on-year and by 3.9% since the previous quarter

Price vs fundamentals

How does NHI's price correlate with its fundamentals

Growth

What is National Health Investors's growth rate over time

Valuation

What is National Health Investors stock price valuation
NHI P/E details
P/E
23.48
P/B
2.33
P/S
8.79
EV/EBIT
23.21
EV/EBITDA
16.4
EV/Sales
11.92
NHI's P/E is 10% less than its 5-year quarterly average of 25.3 and 7% less than its last 4 quarters average of 24.6
National Health Investors's EPS has increased by 2.6% QoQ but it has decreased by 2.2% YoY
NHI's price to book (P/B) is 8% more than its 5-year quarterly average of 2.1 but 5% less than its last 4 quarters average of 2.4
NHI's equity is up by 6% YoY
The company's revenue rose by 17% YoY and by 7% QoQ
The stock's P/S is 13% less than its last 4 quarters average of 9.8 and 5% less than its 5-year quarterly average of 9.0

Efficiency

How efficient is National Health Investors business performance
National Health Investors's return on sales has decreased by 12% YoY and by 3.2% QoQ
The ROE has contracted by 7% YoY but it has grown by 3.1% from the previous quarter
The return on assets has declined by 3.6% year-on-year

Dividends

What is NHI's dividend history
Dividend details
DPS
$3.66
Dividend yield
5.01%
Payout ratio
117.7%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did National Health Investors financials performed over time
The total assets is 113% more than the total liabilities
The total liabilities has grown by 8% from the previous quarter
The total assets has grown by 3.8% YoY and by 3.3% from the previous quarter
The debt is 16% smaller than the equity
The debt to equity has grown by 11% from the previous quarter but it has contracted by 6% YoY
The debt has increased by 9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.